Urologic Health
Non-invasive Bladder Function Diagnostics for Urology Care
Company Overview
Snapshot
Founded in September 2024 by Adam Yaacov and Noam Omer, Urologic Health is an early-stage company with 1–10 employees. The company has successfully raised $11,000,000 across one funding round from two investors. In May 2026, Urologic Health announced an $11 million Seed financing round to advance its non-invasive bladder function monitoring technology.
Business overview
Urologic Health develops the niu System, a non-invasive urodynamic diagnostic platform designed for clinicians to assess bladder dysfunction. This technology captures bladder activity and converts it into clinically meaningful diagnostic data without requiring catheterization. The system aims to help urologists evaluate conditions such as overactive bladder, urinary retention, incontinence, and benign prostatic hyperplasia (BPH) through a more repeatable and patient-friendly workflow. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Diagnostics Devices, Urologic Health serves the healthcare industry, targeting providers in geomarkets including the United States and Israel.
Strategic signal
In May 2026, Urologic Health announced an $11 million Seed financing round. This significant capital injection, secured from investors including Longevity Venture Partners and Edge Medical Ventures, validates the market's confidence in the company's non-invasive bladder function monitoring technology and provides crucial resources for advancing its niu System. For investors, this signals strong early-stage growth potential and a clear path towards further development and commercialization in the urology diagnostics market.
Log in to access full profile ›Company Intelligence Q&A
- What is Urologic Health's primary product?
- Urologic Health's primary product is the niu System, a non-invasive urodynamic diagnostic platform designed for assessing bladder dysfunction.
- When was Urologic Health founded?
- Urologic Health was founded in September 2024.
- Who are the founders of Urologic Health?
- The co-founders of Urologic Health are Adam Yaacov, who serves as CEO, and Noam Omer, who is the CTO.
- What was Urologic Health's most recent funding event?
- In May 2026, Urologic Health announced an $11 million Seed financing round to advance its non-invasive bladder function monitoring technology. This round included investments from Longevity Venture Partners and Edge Medical Ventures.
- Which markets does Urologic Health target?
- Urologic Health targets geomarkets including the United States and Israel, focusing on healthcare providers.